A Diversity Covering (DiCo) Plasmodium vivax apical membrane antigen-1 vaccine adjuvanted with RFASE/RSL10 yields high levels of growth-inhibitory antibodies
Article in Vaccine (February 2024)
The most recent citing publications are shown below. View all 97 publications that cite this research output on Dimensions.
Safety and immunogenicity of BK-SE36/CpG malaria vaccine in healthy Burkinabe adults and children: a phase 1b randomised, controlled, double-blinded, age de-escalation trial
Article in Frontiers in Immunology (October 2023)
Adjuvant physiochemistry and advanced nanotechnology for vaccine development
Article in Chemical Society Reviews (July 2023)